BMRN : BioMarin Pharmaceutical stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-07-09 |
|---|---|---|---|---|
| 2025 | $97.16 | $75.04 | $112.17 | 62.82% |
| 2026 | $121.71 | $113.34 | $129.69 | 103.96% |
| 2027 | $123.28 | $115.54 | $130.48 | 106.59% |
| 2028 | $139.7 | $132.88 | $146.13 | 134.12% |
| 2029 | $141.52 | $132.52 | $145.86 | 137.18% |
| 2030 | $132.49 | $132.39 | $132.6 | 122.03% |
| 2031 | $124.8 | $103.99 | $132.85 | 109.15% |
| 2032 | $82.98 | $78.16 | $94.59 | 39.06% |
| 2033 | $102.36 | $92.69 | $108.79 | 71.54% |
| 2034 | $82.04 | $68.58 | $98.02 | 37.5% |
| 2035 | $68.53 | $68.13 | $69.44 | 14.85% |
The 10 Wall Street analysts offering BioMarin Pharmaceutical stock forecast in the last 6 months have average price target of
$94.4 with a high forecast of $126.0 and a low forecast of $70.0.
The average BioMarin Pharmaceutical stock forecast represents a 58.2%
increase from the last price of $59.6699981689453.
For BioMarin Pharmaceutical stock forecast for 2025, 5 predictions are offered for each month of 2025 with average BioMarin Pharmaceutical stock
forecast of $97.16, a high forecast of $112.17, and a low forecast of $75.04.
The average BioMarin Pharmaceutical stock forecast 2025 represents a 62.82%
increase from the last price of $59.6699981689453.
For BioMarin Pharmaceutical stock forecast for 2026, 12 predictions are offered for each month of 2026 with average BioMarin Pharmaceutical stock
forecast of $121.71, a high forecast of $129.69, and a low forecast of $113.34.
The average BioMarin Pharmaceutical stock forecast 2026 represents a 103.96%
increase from the last price of $59.6699981689453.
For BioMarin Pharmaceutical stock forecast for 2028, 12 predictions are offered for each month of 2028 with average BioMarin Pharmaceutical stock
forecast of $139.7, a high forecast of $146.13, and a low forecast of $132.88.
The average BioMarin Pharmaceutical stock forecast 2028 represents a 134.12%
increase from the last price of $59.6699981689453.
For BioMarin Pharmaceutical stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average BioMarin Pharmaceutical stock
forecast of $132.49, a high forecast of $132.6, and a low forecast of $132.39.
The average BioMarin Pharmaceutical stock forecast 2030 represents a 122.03%
increase from the last price of $59.6699981689453.
For BioMarin Pharmaceutical stock forecast 2031, 12 predictions are offered for each month of 2031 with average BioMarin Pharmaceutical stock
forecast of $124.8, a high forecast of $132.85, and a low forecast of $103.99.
The average BioMarin Pharmaceutical stock forecast 2031 represents a 109.15%
increase from the last price of $59.6699981689453.
For BioMarin Pharmaceutical stock forecast for 2035 (10 year), 7 predictions are offered for each month of 2035 with average BioMarin Pharmaceutical stock
forecast of $68.53, a high forecast of $69.44, and a low forecast of $68.13.
The average BioMarin Pharmaceutical stock forecast 2035 represents a 14.85%
increase from the last price of $59.6699981689453.
Please, see more forecasts below.
BMRN : BioMarin Pharmaceutical stock forecast by Wall Street Analysts
The average BioMarin Pharmaceutical stock forecast from last 6 month is $94.4, and this show a -1.05% decrease in average from the prior price target of the each prediction. Also, this average forecast of $94.4 represents a -3.8% decrease from the past average forecast of $98.13, 6 months ago from 39 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-05-05 | Goldman Sachs | $124.0000 | $104.0000 | Buy |
| 2025-05-02 | Citigroup | $82.00 | $78.0000 | Neutral |
| 2025-02-24 | Oppenheimer | $98.0000 | Outperform | |
| 2025-02-20 | B of A Securities | $99.0000 | $103 | Buy |
| 2025-02-20 | Piper Sandler | $122.00 | $126 | Overweight |
| 2025-02-20 | UBS | $109.0000 | $113.0000 | Buy |
| 2025-02-20 | Cantor Fitzgerald | $90.0000 | $90.0000 | Overweight |
| 2025-02-20 | RBC Capital | $70 | $70.0000 | Sector Perform |
| 2025-02-20 | Citigroup | $81.00 | $82.0000 | Neutral |
| 2025-02-20 | Scotiabank | $78.00 | $80.0000 | Sector Perform |
| 2024-12-12 | Cantor Fitzgerald | $90.00 | $90.0000 | Overweight |
| 2024-11-15 | Wolfe Research | $95.0000 | Outperform | |
| 2024-10-30 | William Blair | Market Perform | ||
| 2024-10-30 | Baird | $72.00 | $65 | Neutral |
| 2024-10-30 | UBS | $104.0000 | $106.0000 | Buy |
| 2024-10-30 | Evercore ISI Group | $115.00 | $105 | Outperform |
| 2024-10-30 | RBC Capital | $80.00 | $80.00 | Sector Perform |
| 2024-10-30 | JP Morgan | $110.0000 | $109.0000 | Overweight |
| 2024-10-30 | Cantor Fitzgerald | $110.00 | $90 | Overweight |
| 2024-10-30 | Canaccord Genuity | $93.00 | $84.0000 | Hold |
| 2024-10-30 | Citigroup | $93.0000 | $81.0000 | Neutral |
| 2024-10-10 | Raymond James | $79.0000 | Outperform | |
| 2024-10-04 | Barclays | $110.00 | $86.0000 | Overweight |
| 2024-10-04 | RBC Capital | $85.00 | $80.0000 | Sector Perform |
| 2024-09-17 | Bernstein | $116.0000 | $90.0000 | Outperform |
| 2024-09-17 | Stifel | $115.00 | $87 | Buy |
| 2024-09-17 | B of A Securities | $130 | $115 | Buy |
| 2024-09-17 | RBC Capital | $100.00 | $85 | Sector Perform |
| 2024-09-17 | Wells Fargo | $115.0000 | $90.0000 | Overweight |
| 2024-09-17 | Truist Securities | $118.00 | $90 | Buy |
| 2024-09-17 | Scotiabank | $95.00 | $78.0000 | Sector Perform |
| 2024-09-13 | Canaccord Genuity | $93.0000 | $93 | Hold |
| 2024-09-09 | Cantor Fitzgerald | $110.00 | $110.0000 | Overweight |
| 2024-09-05 | RBC Capital | $100.00 | $100.00 | Sector Perform |
| 2024-09-05 | JP Morgan | $111.0000 | $120.0000 | Overweight |
| 2024-09-05 | Scotiabank | $86.0000 | $95 | Sector Perform |
| 2024-09-05 | Truist Securities | $140.00 | $118 | Buy |
| 2024-09-05 | Piper Sandler | $107.00 | $122 | Overweight |
| 2024-08-27 | Piper Sandler | $107.00 | $107 | Overweight |
| 2024-08-21 | Stifel | $112.00 | $115 | Buy |
| 2024-08-20 | Bernstein | $94.0000 | $110.0000 | Outperform |
| 2024-08-06 | Evercore ISI Group | $113.0000 | $115 | Outperform |
| 2024-08-06 | Barclays | $111.00 | $110.0000 | Overweight |
| 2024-08-06 | RBC Capital | $100.0000 | $100 | Sector Perform |
| 2024-08-06 | Stifel | $108.0000 | $112 | Buy |
| 2024-08-06 | Scotiabank | $85.00 | $86.0000 | Sector Perform |
| 2024-08-06 | TD Cowen | $125.0000 | $120.0000 | Buy |
| 2024-08-05 | Cantor Fitzgerald | $110.00 | $110.00 | Overweight |
| 2024-07-25 | Canaccord Genuity | $89.00 | $89.0000 | Hold |
| 2024-07-22 | Cantor Fitzgerald | $110.00 | $110.0000 | Overweight |
BioMarin Pharmaceutical stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-07-11 | $61.48 | 3.03% |
| 2025-07-14 | $61.61 | 0.21% |
| 2025-07-15 | $61.51 | -0.16% |
| 2025-07-16 | $62.06 | 0.90% |
| 2025-07-17 | $66.15 | 6.58% |
BMRN : Long term BioMarin Pharmaceutical stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 Aug. is $75.04 , for 2026 Jul. is $124.43 , for 2029 Jul. is $144.86 , for 2030 Jul. is $132.57 , for 2034 Jul. is $76.54 , and for 2035 Jul. is $69.44.
BMRN : BioMarin Pharmaceutical stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Aug. | $75.04 | 25.76% |
| 2025 Sep. | $90.27 | 20.29% |
| 2025 Oct. | $100.07 | 10.86% |
| 2025 Nov. | $108.23 | 8.16% |
| 2025 Dec. | $112.17 | 3.64% |
BMRN : BioMarin Pharmaceutical stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $114.41 | 2.00% |
| 2026 Feb. | $113.82 | -0.52% |
| 2026 Mar. | $113.90 | 0.07% |
| 2026 Apr. | $113.34 | -0.49% |
| 2026 May. | $125.07 | 10.34% |
| 2026 Jun. | $124.99 | -0.06% |
| 2026 Jul. | $124.43 | -0.45% |
| 2026 Aug. | $123.98 | -0.36% |
| 2026 Sep. | $124.12 | 0.11% |
| 2026 Oct. | $125.15 | 0.83% |
| 2026 Nov. | $127.57 | 1.94% |
| 2026 Dec. | $129.69 | 1.66% |
BMRN : BioMarin Pharmaceutical stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $130.00 | 0.24% |
| 2027 Feb. | $129.90 | -0.07% |
| 2027 Mar. | $125.76 | -3.19% |
| 2027 Apr. | $121.81 | -3.14% |
| 2027 May. | $117.00 | -3.95% |
| 2027 Jun. | $115.54 | -1.25% |
| 2027 Jul. | $116.25 | 0.62% |
| 2027 Aug. | $118.48 | 1.92% |
| 2027 Sep. | $121.49 | 2.53% |
| 2027 Oct. | $124.76 | 2.70% |
| 2027 Nov. | $127.83 | 2.46% |
| 2027 Dec. | $130.48 | 2.07% |
BMRN : BioMarin Pharmaceutical stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $132.88 | 1.84% |
| 2028 Feb. | $135.04 | 1.63% |
| 2028 Mar. | $136.20 | 0.86% |
| 2028 Apr. | $138.05 | 1.36% |
| 2028 May. | $140.16 | 1.53% |
| 2028 Jun. | $140.68 | 0.37% |
| 2028 Jul. | $138.55 | -1.52% |
| 2028 Aug. | $139.00 | 0.32% |
| 2028 Sep. | $141.75 | 1.98% |
| 2028 Oct. | $144.58 | 1.99% |
| 2028 Nov. | $146.13 | 1.08% |
| 2028 Dec. | $143.39 | -1.88% |
BMRN : BioMarin Pharmaceutical stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $144.05 | 0.46% |
| 2029 Feb. | $145.29 | 0.86% |
| 2029 Mar. | $145.85 | 0.38% |
| 2029 Apr. | $145.86 | 0.01% |
| 2029 May. | $145.29 | -0.39% |
| 2029 Jun. | $145.00 | -0.20% |
| 2029 Jul. | $144.86 | -0.10% |
| 2029 Aug. | $144.86 | -0.01% |
| 2029 Sep. | $139.08 | -3.99% |
| 2029 Oct. | $133.01 | -4.36% |
| 2029 Nov. | $132.62 | -0.30% |
| 2029 Dec. | $132.52 | -0.07% |
BMRN : BioMarin Pharmaceutical stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $132.42 | -0.08% |
| 2030 Feb. | $132.39 | -0.02% |
| 2030 Mar. | $132.39 | 0.00% |
| 2030 Apr. | $132.42 | 0.02% |
| 2030 May. | $132.48 | 0.04% |
| 2030 Jun. | $132.53 | 0.04% |
| 2030 Jul. | $132.57 | 0.03% |
| 2030 Aug. | $132.60 | 0.02% |
| 2030 Sep. | $132.58 | -0.01% |
| 2030 Oct. | $132.51 | -0.05% |
| 2030 Nov. | $132.43 | -0.06% |
| 2030 Dec. | $132.53 | 0.07% |
BMRN : BioMarin Pharmaceutical stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $132.84 | 0.23% |
| 2031 Feb. | $132.57 | -0.20% |
| 2031 Mar. | $132.85 | 0.21% |
| 2031 Apr. | $132.81 | -0.03% |
| 2031 May. | $132.65 | -0.12% |
| 2031 Jun. | $132.22 | -0.33% |
| 2031 Jul. | $126.48 | -4.33% |
| 2031 Aug. | $121.61 | -3.85% |
| 2031 Sep. | $120.18 | -1.18% |
| 2031 Oct. | $117.63 | -2.12% |
| 2031 Nov. | $111.77 | -4.98% |
| 2031 Dec. | $103.99 | -6.96% |
BMRN : BioMarin Pharmaceutical stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $94.59 | -9.04% |
| 2032 Feb. | $86.56 | -8.49% |
| 2032 Mar. | $82.16 | -5.08% |
| 2032 Apr. | $79.64 | -3.07% |
| 2032 May. | $78.16 | -1.86% |
| 2032 Jun. | $78.17 | 0.02% |
| 2032 Jul. | $78.50 | 0.42% |
| 2032 Aug. | $79.33 | 1.05% |
| 2032 Sep. | $82.41 | 3.88% |
| 2032 Oct. | $84.64 | 2.71% |
| 2032 Nov. | $85.97 | 1.57% |
| 2032 Dec. | $85.59 | -0.45% |
BMRN : BioMarin Pharmaceutical stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $92.69 | 8.30% |
| 2033 Feb. | $100.67 | 8.61% |
| 2033 Mar. | $106.71 | 6.00% |
| 2033 Apr. | $108.79 | 1.94% |
| 2033 May. | $107.81 | -0.90% |
| 2033 Jun. | $105.66 | -1.99% |
| 2033 Jul. | $103.78 | -1.78% |
| 2033 Aug. | $102.38 | -1.35% |
| 2033 Sep. | $101.40 | -0.96% |
| 2033 Oct. | $100.29 | -1.09% |
| 2033 Nov. | $99.42 | -0.87% |
| 2033 Dec. | $98.72 | -0.70% |
BMRN : BioMarin Pharmaceutical stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $98.02 | -0.71% |
| 2034 Feb. | $97.08 | -0.96% |
| 2034 Mar. | $95.57 | -1.56% |
| 2034 Apr. | $92.43 | -3.28% |
| 2034 May. | $92.14 | -0.32% |
| 2034 Jun. | $83.95 | -8.89% |
| 2034 Jul. | $76.54 | -8.83% |
| 2034 Aug. | $71.67 | -6.37% |
| 2034 Sep. | $70.02 | -2.30% |
| 2034 Oct. | $69.57 | -0.64% |
| 2034 Nov. | $68.95 | -0.89% |
| 2034 Dec. | $68.58 | -0.53% |
BMRN : BioMarin Pharmaceutical stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $68.46 | -0.18% |
| 2035 Feb. | $68.38 | -0.12% |
| 2035 Mar. | $68.34 | -0.06% |
| 2035 Apr. | $68.49 | 0.22% |
| 2035 May. | $68.47 | -0.03% |
| 2035 Jun. | $68.13 | -0.49% |
| 2035 Jul. | $69.44 | 1.93% |
Financial Data for BioMarin Pharmaceutical stock
Frequently Asked Questions about BioMarin Pharmaceutical stock forecast
Is BioMarin Pharmaceutical a good long term stock?
From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2025 Aug. is $75.0431202129877 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2026 Jul. is $124.428972952077 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2029 Jul. is $144.864126337382 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2030 Jul. is $132.574768525552 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2034 Jul. is $76.5378213455527 From BioMarin Pharmaceutical stock forecast , BioMarin Pharmaceutical (BMRN) stock can be a good investment choice. According to AIPickup, the BioMarin Pharmaceutical stock price forecast for 2035 Jul. is $69.4419446680751
Is BioMarin Pharmaceutical stock overvalued?
BioMarin Pharmaceutical (BMRN) stock is expected to go UP . Therefore, AIPickup would say that BioMarin Pharmaceutical (BMRN) stock is NOT overvalued.
Will BioMarin Pharmaceutical stock price go up?
Yes. The BioMarin Pharmaceutical stock price forecast for 2026 Jul. is $124.428972952077
Is BioMarin Pharmaceutical stock a good buy now?
Since closing price on 2025-07-09 is $59.6699981689453 and forecast for 2026 Jul. is $124.43, BioMarin Pharmaceutical stock is a good 1 year investment.
14 Days Historical Data for BioMarin Pharmaceutical stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| BMRN stock price for 2025-06-18 | $55.24 | $55.23 | $54.46 | $55.77 |
| BMRN stock price for 2025-06-20 | $55.00 | $55.64 | $54.79 | $56.25 |
| BMRN stock price for 2025-06-23 | $54.08 | $55.08 | $53.72 | $56.00 |
| BMRN stock price for 2025-06-24 | $54.69 | $54.50 | $53.72 | $54.86 |
| BMRN stock price for 2025-06-25 | $54.14 | $54.42 | $53.98 | $54.61 |
| BMRN stock price for 2025-06-26 | $54.10 | $54.46 | $53.76 | $54.55 |
| BMRN stock price for 2025-06-27 | $55.17 | $54.23 | $53.99 | $55.20 |
| BMRN stock price for 2025-06-30 | $54.97 | $55.40 | $54.40 | $55.96 |
| BMRN stock price for 2025-07-01 | $56.19 | $54.64 | $54.63 | $56.66 |
| BMRN stock price for 2025-07-02 | $57.17 | $56.19 | $56.19 | $57.61 |
| BMRN stock price for 2025-07-03 | $57.50 | $57.46 | $57.03 | $58.07 |
| BMRN stock price for 2025-07-07 | $57.41 | $56.97 | $56.76 | $58.00 |
| BMRN stock price for 2025-07-08 | $57.99 | $57.31 | $57.19 | $59.37 |
| BMRN stock price for 2025-07-09 | $59.67 | $58.35 | $58.21 | $59.98 |